Eric S. Hall, PhD

Associate Director for Clinical Informatics, Division of Biomedical Informatics

Co-Director, Biomedical Informatics Graduate Program, Division of Biomedical Informatics

Member, Perinatal Institute

Academic Affiliations

Associate Professor, UC Department of Pediatrics

Phone 513-803-2083

Fax 513-803-0968


Biomedical informatics; clinical informatics; data linkage; infant mortality; maternal child health; neonatal abstinence syndrome; preterm birth; public health informatics
Dr. Hall is a biomedical informatician and researcher focused on improving health outcomes in high-risk perinatal and pediatric populations through novel integration and analysis of disparate maternal-child health data sets. His primary focus areas include preventing infant mortality and improving outcomes for children who experience prenatal opioid exposures. His interests have expanded beyond the hospital setting where high-risk children receive treatment, to the community setting with an increased focus on prediction and prevention of poor outcomes among at-risk populations.

PhD: University of Utah, Salt Lake City, UT, 2008.

MS: Brigham Young University, Provo, UT, 2003.

BS: Brigham Young University, Provo, UT, 2001.

View Publications on Google Scholar

Hall ES, McAllister JM, Wexelblatt SL. Developmental disorders and medical complications among infants with subclinical intrauterine opioid exposures. Popul Health Manag. 2018.

Hall ES, Greenberg JM, Muglia LJ, Divekar P, Zahner J, Gholap J, Leonard M, Marsolo K. Implementation of a regional perinatal data repository from clinical and billing records. Matern Child Health J. 2018 Apr;22(4):485-93.

Hall ES, Wexelblatt SL, Greenberg JM. Surveillance of intrauterine opioid exposures using electronic health records. Popul Health Manag. 2018..

Goyal NK, DeFranco EA, Kamath-Rayne BD, Beck AF, Hall ES. County-level variation in infant and fetal death reporting at early previable gestational ages. Paediatr Perinat Epidemiol. 2017 Sep;31(5):385-91. 

Hall ES, Greenberg JM. Estimating community-level costs of preterm birth. Public Health. 2016 Dec;141(12):222-8.  

Hall ES, Wexelblatt SL, Greenberg JM. Self-reported and laboratory evaluation of late pregnancy nicotine exposure and drugs of abuse. J Perinatol. 2016 Oct;36(10):814-8.

Hall ES, Isemann BT, Wexelblatt SL, Meinzen-Derr J, Wiles JR, Harvey S, Akinbi HT. A cohort comparison of buprenorphine versus methadone treatment for neonatal abstinence syndrome. J Pediatr. 2016 Mar;170:39-44.e1.

Hall ES, Meinzen-Derr J, Wexelblatt SL. Cohort analysis of a pharmacokinetic-modeled methadone weaning optimization for neonatal abstinence syndrome. J Pediatr. 2015 Dec;167(6):1221-1225.e1.

Hall ES, Wexelblatt SL, Crowley M, Grow JL, Jasin LR, Klebanoff MA, McClead RE, Meinzen-Derr J, Mohan VK, Stein H, Walsh MC; OCHNAS Consortium. Implementation of a neonatal abstinence syndrome weaning protocol: A multicenter cohort study. Pediatrics. 2015 Oct;136(4):e803-10.

Hall ES, Wexelblatt SL, Crowley M, Grow JL, Jasin LR, Klebanoff MA, McClead RE, Meinzen-Derr J, Mohan VK, Stein H, Walsh MC. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome. Pediatrics. 2014 Aug;134(2):e527-34.